Dyfrig Hughes - Research outputs

Hughes, D., Thomson, C., Beggs, I., Martin, D., McCaldin, D., Russell, D., Edwards, R. T., Hughes, D. A., Yeo, S. T., Russell, I. T. & Gibson, T. N., 1 Mar 2007.

Research output: Contribution to conference › Paper

Published

Effects of the abolition of prescription charges in Wales: A preliminary analysis

Hughes, D., Hughes, D. A., Alam, F., Cohen, D., Dunstan, F. & Routledge, P., 1 Apr 2008.

Research output: Contribution to conference › Paper

Published

Eliciting patients' preferences using a discrete choice experiment questionnaire: the role played by qualitative data in questionnaire design

Hughes, D., Longo, M., Hughes, D. A., Myles, S. & Lisles, C., 1 Mar 2006.

Research output: Contribution to conference › Paper

Published

Empirical analysis of the relationship between dose and duration of drug action

Hughes, D. & Hughes, D. A., 1 Jun 2005.

Research output: Contribution to conference › Paper

Published

Engaging with the MRC Methodology Hubs – NWHTMR.

Hughes, D. & Hughes, D. A., 1 Jan 2009.

Research output: Contribution to conference › Paper

Published

Enhancing methodical approaches for studying bilingualism in healthcare communication: report of a trial feasibility study.

Roberts, G. W., Hughes, D., Roberts, G., Owen, H., Hughes, L., Whitaker, R., Deuchar, M., Hughes, D. A., Llewelyn, S., John, S., Irvine, F., Owen, B. & Rowlands, A., 1 Jan 2010.

Research output: Contribution to conference › Paper

Published

Factors influencing user choices to visit either general practitioners or community pharmacists for minor ailments – a discrete choice experiment

Hughes, D., Hughes, D. A., Myles, S., Longo, M., Lisles, C. & Hood, K., 1 May 2007.

Research output: Contribution to conference › Paper

Published

Falls and hip-fractures: A cost-effectiveness analysis of risk assessment and interventions for community-dwelling older people

Hughes, D., Gwynne, D., Hughes, D. A. & Edwards, R. T., 1 Mar 2007.

Research output: Contribution to conference › Paper

Published

Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire

Hughes, D. & Hughes, D. A., 1 May 2007.

Research output: Contribution to conference › Paper

Published

Feasibility, validity and reliability of the Welsh EQ-5D health status questionnaire

Hughes, D., 1 Mar 2007.

Research output: Contribution to conference › Paper

Published

From efficacy to cost-effectiveness: Impact of patient compliance

Hughes, D. & Hughes, D. A., 1 Feb 2008.

Research output: Contribution to conference › Paper

Published

From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics

Hughes, D. & Hughes, D. A., 1 May 2002.

Research output: Contribution to conference › Paper

Published

From efficacy to effectiveness and cost-effectiveness: modelling possibilities

Hughes, D. & Hughes, D. A., 1 Nov 2004.

Research output: Contribution to conference › Paper

Published

Health and economic outcomes: Why compliance matters

Hughes, D. & Hughes, D. A., 1 Apr 2006.

Research output: Contribution to conference › Paper

Published

Impact of non-compliance on the clinical and cost-effectiveness of statins

Hughes, D. & Hughes, D. A., 1 Nov 2001.

Research output: Contribution to conference › Paper

Published

Impact of non-compliance on the cost-effectiveness of pharmaceuticals

Hughes, D. & Hughes, D. A., 1 Nov 2002.

Research output: Contribution to conference › Paper

Published

Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.

Hughes, D., Hughes, D. A., Al-Zubiedi, S., Hanson, A., Jorgensen, A. & Pirmohamed, M., 1 Jan 2009.

Research output: Contribution to conference › Paper

Published

Impact of the abolition of prescription charges in Wales: a multi-level modelling approach with application to time series dispensed rate data

Hughes, D., Alam, F., Myles, S., Hughes, D. A., Dunstan, F., Routledge, P. & Cohen, D., 1 Sept 2007.

Research output: Contribution to conference › Paper

Published

Impact of the abolition of the prescription charge in Wales

Hughes, D. & Hughes, D. A., 1 Nov 2008.

Research output: Contribution to conference › Paper

Published

Impact of the abolition of the prescription charge in Wales.

Hughes, D., Hughes, D. A., Alam, M. F., Cohen, D., Dunstan, F., Groves, S. & Routledge, P., 1 Jan 2009.

Research output: Contribution to conference › Paper

Published

Impact of the abolition of the prescription charge in Wales.

Hughes, D., Hughes, D. A., Alam, M. F., Cohen, D., Dunstan, F., Groves, S. & Routledge, P., 1 Jan 2009.

Research output: Contribution to conference › Paper

Published

Impact of the abolition of the prescription charge in Wales.

Hughes, D., Hughes, D. A., Alam, M. F., Cohen, D., Dunstan, F., Groves, S. & Routledge, P., 1 Jan 2009, p. O41.

Research output: Contribution to conference › Paper

Published

Incorporating measures of compliance and persistence in pharmacoeconomic evaluations

Hughes, D., Hughes, D. A. & Cowell, W., 1 Nov 2005.

Research output: Contribution to conference › Paper

Published

Integrating compliance and persistence in health economics models

Hughes, D. & Hughes, D. A., 1 Jan 2008.

Research output: Contribution to conference › Paper

Published

Interventions that enhance medication compliance and persistence: Theoretical grounding, and economic assessment

Hughes, D., Hughes, D. A., Gwadry Sridhar, F., Elliott, R. & Cowell, W., 1 Oct 2007.

Research output: Contribution to conference › Paper

Published

Introduction to pharmaeconomics

Hughes, D. & Hughes, D. A., 1 Jul 2004.

Research output: Contribution to conference › Paper

Published

Investigating factors influencing user choices to visit either general practitioners or community pharmacists in the management of minor ailments

Hughes, D. & Hughes, D. A., 1 May 2006.

Research output: Contribution to conference › Paper

Published

Investigating factors influencing user choices to visit either general practitioners or community pharmacists in the management of minor ailments - piloting a discrete choice experiment

Hughes, D., Myles, S., Hughes, D. A., Longo, M. & Lisles, C., 1 Jun 2006.

Research output: Contribution to conference › Paper

Published

Methodological issues in the literature on costs of non-compliance in chronic diseases

Hughes, D., Salas, M., Zuluaga, A., Hughes, D. A., Cowell, W., Lebmeie, M., Vardeva, K., Pisu, M. & Shinogle, J., 1 Nov 2008.

Research output: Contribution to conference › Paper

Published

Modelling changes in first line antimalarial therapy

Hughes, D. & Hughes, D. A., 1 Sept 2003.

Research output: Contribution to conference › Paper

Published

Orphan drug treatments: economic considerations

Hughes, D. & Hughes, D. A., 1 Nov 2007.

Research output: Contribution to conference › Paper

Published

Patient compliance and persistence with prescribed medication: Measurement and health economic impact

Hughes, D., Koncz, T., Hughes, D. A., Cleemput, I. & Annemans, L., 1 May 2004.

Research output: Contribution to conference › Paper

Published

Patient compliance and pharmacoeconomics

Hughes, D. & Hughes, D. A., 1 Nov 2002.

Research output: Contribution to conference › Paper

Published

Patient compliance and pharmacoeconomics

Hughes, D. & Hughes, D. A., 1 Oct 2001.

Research output: Contribution to conference › Paper

Published

Pharmacoeconomic evaluations in Ireland, Scotland and Wales: A Celtic perspective on pharmaceutical assessment

Hughes, D., Hughes, D. A., Drummond, M., Tolley, K. & Ryan, M., 1 Oct 2007.

Research output: Contribution to conference › Paper

Published

Pharmacoeconomic models that incorporate non-compliance

Hughes, D. & Hughes, D. A., 1 Jul 2004.

Research output: Contribution to conference › Paper

Published

Pharmacoeconomics appraisals by the all Wales medicines strategy group

Hughes, D. & Hughes, D. A., 1 Jul 2004.

Research output: Contribution to conference › Paper

Published

Pharmacoeconomics in Wales: functions of the all Wales medicines strategy group

Hughes, D. & Hughes, D. A., 1 Apr 2004.

Research output: Contribution to conference › Paper

Published

Pharmacoeconomics of pharmacogenetic testing: azathioprine

Hughes, D., McAllister, R. & Hughes, D. A., 1 Apr 2004.

Research output: Contribution to conference › Paper

Published

Pharmacokinetics, patient compliance and pharmaeconomics

Hughes, D. & Hughes, D. A., 1 Jun 2005.

Research output: Contribution to conference › Paper

Published

Pharmacometric analysis of duration of drug action: implications for improved forgiveness to medication non-compliance

Hughes, D., Hughes, D. A. & Walley, T., 1 Sept 2001.

Research output: Contribution to conference › Paper

Published

Physchiatrist prescribing preferences and attitudes toward promotion

Hughes, D., Menkes, D., Davies, R. & Hughes, D. A., 1 Apr 2006.

Research output: Contribution to conference › Paper

Published

Population pharmacokinetics of warfarin: Intermin analysis of the Liverpool pharmacogenetic prospective cohort study

Hughes, D., Matthews, I., Aarons, L., Al-Zubiedi, S., Hatch, E., Lane, S., Williamson, P., Kamali, F., Hughes, D. A. & Pirmohamed, M., 1 Nov 2007.

Research output: Contribution to conference › Paper

Published

Pragmatic trials - design features and implications for clinical decision making

Hughes, D., Urdahl, H., Hughes, D. A. & Freemantle, N., 1 Aug 2000.

Research output: Contribution to conference › Paper

Published

Prescription fee exemption research study

Hughes, D., Myles, S., Hughes, D. A., Routledge, P. & Wales, D. F., 1 Jun 2006.

Research output: Contribution to conference › Paper

Published

Public funding of drugs for orphan diseases

Hughes, D. & Hughes, D. A., 1 Jul 2005.

Research output: Contribution to conference › Paper

Published

Public funding of drugs for orphan diseases

Hughes, D. & Hughes, D. A., 1 Jan 2006.

Research output: Contribution to conference › Paper

Published

Public funding of drugs for orphan diseases

Hughes, D. & Hughes, D. A., 1 Nov 2005.

Research output: Contribution to conference › Paper

Published

Public funding of drugs for orphan diseases

Hughes, D. & Hughes, D. A., 1 Nov 2005.

Research output: Contribution to conference › Paper

Published

Public meetings of the NICE appraisals committee

Hughes, D. & Hughes, D. A., 1 Dec 2007.

Research output: Contribution to conference › Paper

Published

Quantitative risk-benefit analysis

Hughes, D. & Hughes, D. A., 1 May 2007.

Research output: Contribution to conference › Paper

Published

Rationing of drugs for rare diseases

Hughes, D. & Hughes, D. A., 1 Apr 2006.

Research output: Contribution to conference › Paper

Published

Systematic review of follow-up of cancer in primary care verses secondary care: findings for breast and lung cancer

Hughes, D., Lewis, R., Neal, R. D., France, B., Williams, N. H., Wilkinson, C., Russell, I. T., Russell, D., Hughes, D. A., Stuart, N. S. & Weller, D., 1 Mar 2007.

Research output: Contribution to conference › Paper

Published

The all wales medicines strategy group: assessments and appraisals

Hughes, D. & Hughes, D. A., 1 Nov 2008.

Research output: Contribution to conference › Paper

Published

The assessment, determinants & economics of medication compliance & persistence

Hughes, D., Hughes, D. A., Gwadry Sridhar, F. & Elliott, R., 1 Oct 2007.

Research output: Contribution to conference › Paper

Published

The cost-effectiveness of biological therapies for Crohn's disease: Markov cohort analyses incorporating UK patient-level cost data

Hughes, D., Bodger, K., Kikuchi, T. & Hughes, D. A., 1 Mar 2008.

Research output: Contribution to conference › Paper

Published

The cost-effectiveness of biological therapies for Crohn's disease: markov cohot analyses incorporating UK patient-level cost data

Hughes, D., Hughes, D. A., Bodger, K. & Kikuchi, T., 1 May 2008.

Research output: Contribution to conference › Paper

Published

The economics of evergreening.

Hughes, D. & Hughes, D. A., 1 Jan 2009.

Research output: Contribution to conference › Paper

Published

The effect of compliance upon clinical effectiveness of chlorproguanil-dapsone (CD) and artemether-lumefantrine (AL) when compared to sulfadoxine-pyrimethamine (SP) for the treatment of uncomplicated falcipaum malaria in Malawi - a randomised controlled trial

Hughes, D., Bell, D. J., Wootton, D., Mukaka, M., Montgomery, J., Kayange, N., Chimpeni, P., Zijlstra, E., Hughes D.A., [. V., Molyneux M.E.*, [. V., Ward, S. A., Winstanley, P. A. & Lalloo, D. G., 1 Nov 2007.

Research output: Contribution to conference › Paper

Published

The influence of non-compliance on the effectiveness and cost-effectiveness of drug therapies

Hughes, D., Hughes, D. A., Bagust, A., Haycox, A. & Walley, T., 1 Nov 2000.

Research output: Contribution to conference › Paper

Published

The pharmacokinetic profile of Warfarn: a systematic review

Hughes, D., Al-Zubiedi S.*, [. V., Hughes D.A., [. V. & Pirmohamed, M., 1 Dec 2007.

Research output: Contribution to conference › Paper

Published

The population pharmacokinetics of lapdap

Hughes, D., Ward, S., Simpson, J., Aarons, L., Szwandt, S. & Hughes, D. A., 1 Nov 2002.

Research output: Contribution to conference › Paper

Published

Ultra-long acting pharmaceuticals: Do they result in better outcomes, and at an acceptable cost?

Hughes, D. & Hughes, D. A., 1 Nov 2006.

Research output: Contribution to conference › Paper

Published

Use of PK-PD modelling to predict the impact of non-compliance

Hughes, D. & Hughes, D. A., 1 Nov 2003.

Research output: Contribution to conference › Paper

Published

What determines which interventions improve compliance, and do they improve health outcomes in a cost-effective manner?

Hughes, D., Hughes, D. A., LaFleur.*, [. V., Salas, M. & Shinogle, J., 1 May 2007.

Research output: Contribution to conference › Paper

Published

A Systematic Review of Patient Preferences for Subcutaneous Medications

Ridyard, C., Dawoud, D. & Hughes, D., Nov 2013.

Research output: Contribution to conference › Paper › peer-review

Published

Identification Of Items For A Standardised Resource-Use Measure: Review Of Current Instruments

Thorn, J. C., Ridyard, C., Riley, R., Brookes, S., Hughes, D., Wordsworth, S., Noble, S. & Hollingworth, W., Nov 2015.

Research output: Contribution to conference › Paper › peer-review

Published

Review of the Use of Resource Use Instruments Based on Patient Recall in Relation to Other Methods of Cost Estimation

Ridyard, C. & Hughes, D., Nov 2013.

Research output: Contribution to conference › Paper › peer-review

Published

Review of the use of resource use instruments based on patient recall in relation to other methods of resource use estimation

Ridyard, C. & Hughes, D., Nov 2013.

Research output: Contribution to conference › Paper › peer-review

Published

Screening log data can be used to inform protocol modifications, increasing patient recrutiment to a challanging clinical trial

Blair, J., Awoyale, L., Thornborough, K., Peak, M., Didi, M., Bedson, E., Hughes, D., Ridyard, C., Tat, T. & Gregory, J., Nov 2013.

Research output: Contribution to conference › Paper › peer-review

Published

Carer-administration of as-needed sub-cutaneous medication for breakthrough symptoms in homebased dying patients: a UK study (CARIAD)

Wilkinson, C., Poolman, M., Roberts, J., Wee, B., Hiscock, J., Hughes, D., Nelson, A., Perkins, P., Johnstone, R. P., Reymond, E., Foster, B., O'Connor, J., Jones, S., Hoare, Z., Roberts, R., Byrne, A., Healy, S. & Lewis, P., 1 Sept 2017.

Research output: Contribution to conference › Poster › peer-review

Published

Comparison of regression methods for the cost effectiveness analysis of clinical trials with a small population size: the sycamore and folated trials

Culeddu, G., Hughes, D. & Welton, N., 10 Jul 2017.

Research output: Contribution to conference › Poster › peer-review

Published

Core items for a standardised resource-use measure (ISRUM):expert Delphi consensus survey

Thorn, J., Ridyard, C., Riley, R., Brookes, S., Hughes, D., Wordsworth, S., Noble, S., Thornton, G. & Hollingworth, W., 7 May 2017, p. P265. 1 p.

Research output: Contribution to conference › Poster › peer-review

Published

Health Economics Analysis Plans: Where Are We Now?

Thorn, J., Ridyard, C., Hughes, D., Wordsworth, S., Mihaylova, B., Noble, S. & Hollingworth, W., 3 Nov 2016, p. A397. 1 p.

Research output: Contribution to conference › Poster › peer-review

Published

Health economics analysis plans: the current state of play

Thorn, J., Ridyard, C., Hughes, D., Wordsworth, S., Mihaylova, B., Noble, S. & Hollingworth, W., 7 May 2017, p. P144. 1 p.

Research output: Contribution to conference › Poster › peer-review

Published

Patient-level information and costing systems (PLICS) as a source of routinely collected cost data for trial-based economic evaluations

Ridyard, C. & Hughes, D., 7 May 2017, p. P141. 1 p.

Research output: Contribution to conference › Poster › peer-review

Published

Continuous subcutaneous insulin infusion compated to multiple daily injection regimens in children and yung people at diagnosis of type 1 diabetes: A pragmatic randomised controlled trial and economic evaluation (scipi trial)

Blair, J., Mckay, A., Ridyard, C., Thornborough, K., Bedson, E., Peak, M., Didi, M., Annan, F., John, G., Hughes, D. & Gamble, C., Sept 2017, p. 22-23.

Research output: Contribution to conference › Abstract › peer-review

Published

Cost-Effectiveness Analysis of Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa

Culeddu, G., Brogan, P. A. & Hughes, D., 2021.

Research output: Contribution to conference › Other › peer-review

Published

A review of economic models for second-line chemotherapy in the management of advanced, metastatic breast cancer.

Hughes, D. & Hughes, D. A., 1 Jan 2001, 2001 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

AWMSG criteria for appraising new medicines.

Hughes, D. & Hughes, D. A., 1 Jan 2007, 2007 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

All Wales Medicines Strategy Group Final Appraisal Report - Abacavir 600mg/lamivudine 300mg (Kivexa) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

All Wales Medicines Strategy Group Final Appraisal Report - Ambrisentan (Volibris) for pulmonary arterial hypertension.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2009, 2009 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

All Wales Medicines Strategy Group Final Appraisal Report - Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2009, 2009 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-experienced patients.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-naïve patients.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

All Wales Medicines Strategy Group Final Appraisal Report - Buprenorphine/naloxone (Suboxone) as substitution treatment for opioid dependence.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

All Wales Medicines Strategy Group Final Appraisal Report - Deferasirox (Exjade) for the treatment of chronic iron overload due to blood transfusions.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

All Wales Medicines Strategy Group Final Appraisal Report - Docetaxel (Taxotere) for locally advanced squamous cell carcinoma of the head and neck.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

Research output: Book/Report › Commissioned report

Research Portal

Professor Dyfrig Hughes

Affiliations

Links